Woebot Health develops AI-powered digital mental health platforms designed to deliver evidence-based psychological interventions via conversational agents. The company’s flagship product, Woebot, provides text-based therapy incorporating cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT). Its approach focuses on accessible, scalable mental health support through automated, personalized interactions. Woebot Health positions its technology within digital therapeutics and behavioral health care contexts.

The technology uses AI-driven natural language processing to engage users in real-time conversation, delivering therapeutic exercises, psychoeducation, and mood tracking. Algorithms adapt interactions based on user responses, promoting engagement and reinforcing learning. The platform emphasizes continuous availability, structured evidence-based interventions, and user-friendly design. This approach prioritizes scalability and accessibility over in-person clinician contact.

Woebot Health targets individuals seeking mental health support, including management of stress, anxiety, and depression, in a convenient and discreet format. The platform is intended to complement traditional care rather than replace licensed therapists. Its positioning reflects broader trends toward AI-enabled digital therapeutics that democratize access to mental health interventions.